Effects of clinically relevant doses of methyphenidate on spatial memory, behavioral sensitization and open field habituation: A time related study

Behavioural Brain Research

Volumn 281, Issue , 2015, Pages 208-214

  Haleem, Darakhshan Jabeen ^a   Inam, Qurrat ul Aen ^a   Haleem, Muhammad Abdul ^b  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b SIR SYED UNIVERSITY OF ENGINEERING AND TECHNOLOGY   (Pakistan)

Author keywords

Attention deficit hyperactivity disorder; Cognition; Emotion; Methylphenidate; Morris water maze test; Open field activity; Ritalin

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG EFFECT; EXPLORATORY BEHAVIOR; HABITUATION; MALE; MEMORY CONSOLIDATION; MORRIS WATER MAZE TEST; MOTOR ACTIVITY; NONHUMAN; OPEN FIELD TEST; RAT; REINFORCEMENT; SENSITIZATION; SPATIAL MEMORY; TASK PERFORMANCE; ANIMAL; ANIMAL BEHAVIOR; DOSE RESPONSE; DRUG EFFECTS; LOCOMOTION; MAZE TEST; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HABITUATION, PSYCHOPHYSIOLOGIC; LOCOMOTION; MALE; MAZE LEARNING; METHYLPHENIDATE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SPATIAL MEMORY;

EID: 84920177666     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.12.031     Document Type: Article

References (54)

1. Baumeister A.A., Henderson K., Pow J.L., Advokat C. The early history of the neuroscience of attention-deficit/hyperactivity disorder. J Hist Neurosci 2012, 21:263-279.
2. Hodgkins P., Shaw M., Coghill D., Hechtman L. Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options. Eur Child Adolesc Psychiatry 2012, 21:477-492.
3. Opler L.A., Frank D.M., Ramirez P.M. Psychostimulants in the treatment of adults with psychosis and attention deficit disorder. Ann N Y Acad Sci 2001, 931:297-301.
4. McCabe S.E., Knight J.R., Teter C.J., Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005, 100:96-106.
5. Swanson J., Castellanos F.X., Murias M., LaHoste G., Kennedy J. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 1998, 8:263-271.
6. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M., Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000, 283:1025-1030.
7. Spencer T., Biederman J., Wilens T., Harding M., O'Donnell D., Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996, 35:409-432.
8. Biederman J., Spencer T., Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 2004, 7:77-97.
9. Mészáros A., Czobor P., Bálint S., Komlósi S., Simon V., Bitter I. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol 2009, 12:1137-1147.
10. Diller L.H. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990. Hastings Cent Rep 1996, 26:12-18.
11. Maher B. Poll results: look who's doping. Nature 2008, 452:674-675.
12. Gerasimov M.R., Franceschi M., Volkow N.D., Rice O., Schiffer W.K., Dewey S.L. Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor. Synapse 2000, 38:432-437.
13. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., Molina P.E., Dewey S.L. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. Pharmacol Exp Ther 2000, 295:51-57.
14. Kuczenski R., Segal D.S. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry 2005, 57:1391-1396.
15. Britton G.B. Cognitive and emotional behavioural changes associated with methylphenidate treatment: a review of preclinical studies. Int J Neuropsychopharmacol 2012, 15:41-53.
16. Huang F.L., Huang K.P. Methylphenidate improves the behavioral and cognitive deficits of neurogranin knockout mice. Genes Brain Behav 2012, 11:794-805.
17. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
18. White F.J., Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 1998, 51:141-153.
19. Haleem D.J. Extending therapeutic use of psychostimulants: focus on serotonin-1A receptor. Prog Neuropsychopharmacol Biol Psychiatry 2013, 46:170-180.
20. Yang P.B., Swann A.C., Dafny N. Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization. Brain Res 2007, 1145:66-80.
21. Yang P.B., Swann A.C., Dafny N. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res Bull 2006, 71:301-310.
22. Volkow N.D., Wang G.J., Fowler J.S., Hitzemann R., Gatley J., Ding Y.S., Wong C., Pappas N. Differences in regional brain metabolic responses between single and repeated doses of methylphenidate. Psychiatry Res 1998, 83:29-36.
23. Haleem D.J., Farhan M. Inhibition of apomorphine-induced behavioral sensitization in rats pretreated with fluoxetine. Behav Pharmacol 2014, (in press).
24. Haleem D.J. Neurochemistry, neuropharmacology and behavior 2010, VDM Publishers, Germany.
25. Morris R.G. Spatial localization does not depend on the presence of local cues. Learn Motiv 1981, 12:239-260.
26. Haider S., Khaliq S., Tabassum S., Haleem D.J. Role of somatodendritic and postsynaptic 5-HT,A receptors on learning and memory functions in rats. Neurochem Res 2012, 37:2161-2166.
27. Haider S., Saleem S., Perveen T., Tabassum S., Batool Z., Sadir S., Liaquat L., Madiha S. Age-related learning and memory deficits in rats: role of altered brain neurotransmitters, acetylcholinesterase activity and changes in antioxidant defense system. Age (Dordr) 2014, 36:1291-1302.
28. Scherer E.B., da Cunha M.J., Matté C., Schmitz F., Netto C.A., Wyse A.T. Methylphenidate affects memory, brain-derived neurotrophic factor immunocontent and brain acetylcholinesterase activity in the rat. Neurobiol Learn Mem 2010, 94:247-253.
29. Zhu N., Weedon J., Dow-Edwards D.L. Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats. Behav Neurosci 2007, 121:1272-1279.
30. Amos-Kroohs William M.T., Vorhees C.V. Neonatal methylphenidate does not impair adult spatial learning in the Morris water maze in rats. Neurosci Lett 2011, 502:152-156.
31. Carmack S.A., Block C.L., Howell K.K., Anagnostaras S.G. Methylphenidate enhances acquisition and retention of spatial memory. Neurosci Lett 2014, 567:45-50.
32. Carmack S.A., Howell K.K., Rasaei K., Reas E.T., Anagnostaras S.G. Animal model of methylphenidate's long-term memory-enhancing effects. Learn Mem 2014, 21:82-89.
33. Veetil P.K., Mukkadan J.K. Effect of methylphenidate on enhancement of spatial learning by novel alternated dual task. Indian J Physiol Pharmacol 2011, 55:176-182.
34. Myers K.M., Davis M. Behavioral and neural analysis of extinction. Neuron 2002, 36:567-584.
35. Rescorla R.A. Are associative changes in acquisition and extinction negatively accelerated. J Exp Psychol Anim Behav Process 2001, 27:307-315.
36. Debiec J., LeDoux J.E., Nader K. Cellular and systems reconsolidation in the hippocampus. Neuron 2002, 36:527-538.
37. Eisenberg M., Kobilo T., Berman D.E., Dudai Y. Stability of retrieved memory: inverse correlation with trace dominance. Science 2003, 301:1102-1104.
38. Pedreira M.E., Maldonado H. Protein synthesis subserves reconsolidation or extinction depending on reminder duration. Neuron 2003, 38:863-869.
39. Spencer R.C., Klein R.M., Berridge C.W. Psychostimulants act within the prefrontal cortex to improve cognitive function. Biol Psychiatry 2012, 72:221-227.
40. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., Hamilton C., Spencer R.C. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006, 60:1111-1120.
41. Devilbiss D.M., Berridge C.W. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biol Psychiatry 2008, 64:626-635.
42. Berridge C.W., Arnsten A.F. Psychostimulants and motivated behavior: arousal and cognition. Neurosci Biobehav Rev 2013, 37:1976-1984.
43. Arnsten A.F., Dudley A.G. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct 2005, 1(2):1-9.
44. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., Hitzemann R., Pappas N. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 1998, 155:1325-1331.
45. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001, 21:9414-9418.
46. Markowitz J.S., DeVane C.L., Ramamoorthy S., Zhu H.J. The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor. Pharmazie 2009, 64:123-125.
47. Nishikawa T., Mataga N., Takashima M., Toru M. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur J Pharmacol 1983, 88:195-203.
48. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986, 396:157-198.
49. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000, 151(2-3):99-120.
50. Berridge K.C., Robinson T.E., Aldridge J.W. Dissecting components of reward: 'liking', 'wanting', and learning. Curr Opin Pharmacol 2009, 9:65-73.
51. Bolaños C.A., Barrot M., Berton O., Wallace-Black D., Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 2003, 54:1317-1329.
52. Carlezon W.A, Mague S.D., Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 2003, 54:1330-1337.
53. Wiley M.D., Poveromo L.B., Antapasis J., Herrera C.M., Bolaños Guzmán C.A. Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate. Neuropsychopharmacology 2009, 34:1339-1350.
54. Heredia L., Torrente M., Colomina M.T., Domingo J.L. Assessing anxiety in C57BL/6J mice: a pharmacological characterization of the open-field and light/dark tests. J Pharmacol Toxicol Methods 2014, 69(2):108-114.